Literature DB >> 8268221

Characterization of regulatory sequences and nuclear factors that function in cooperation with the promoter of the human thymidylate synthase gene.

N Horie1, M Chimoto, R Nozawa, K Takeishi.   

Abstract

To identify the essential sequence of the promoter of the human thymidylate synthase (hTS) gene, deletion mutants were constructed and assayed for promoter activity. The essential sequence was located within 65 bp upstream from the major cap site and a sequence that reduces the promoter activity was found in a region upstream from the essential promoter sequence. We previously identified two DNA-binding nuclear factors, NF-TS2 and NF-TS3, that bind to a region around the site of initiation of translation of the hTS gene. In this study, we confirmed the binding site of these factors by gel mobility shift analysis and found that NF-TS2 is the major factor that binds to the hTS gene in HeLa cells, whereas NF-TS3 is the major factor in the TIG-1 line of human fibroblast cells. To clarify the function of these factors, we examined the effects of the binding of these factors on the promoter activity. Our findings suggest that the binding of NF-TS2 enhances the promoter activity of the hTS gene in HeLa cells, whereas the binding of NF-TS3 represses the activity of the same promoter in TIG-1 cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8268221     DOI: 10.1016/0167-4781(93)90008-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Thymidylate synthase gene polymorphism as a prognostic factor for colon cancer.

Authors:  Kwang Wook Suh; Joo Hyung Kim; Young Bae Kim; Jeongmi Kim; Soohyun Jeong
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

2.  Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy.

Authors:  Vienna Ludovini; Cinzia Antognelli; Antonio Rulli; Jennifer Foglietta; Lorenza Pistola; Rulli Eliana; Irene Floriani; Giuseppe Nocentini; Francesca Romana Tofanetti; Simonetta Piattoni; Elisa Minenza; Vincenzo Nicola Talesa; Angelo Sidoni; Maurizio Tonato; Lucio Crinò; Stefania Gori
Journal:  BMC Cancer       Date:  2017-07-26       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.